Epigenomic effects of vitamin D in colorectal cancer.

Vitamin D regulates a plethora of physiological processes in the human body and has been proposed to exert several anticancer effects. Epigenetics plays an important role in regulating vitamin D actions. In this review, we highlight the recent advances in the understanding of different epigenetic factors such as lncRNAs, miRNAs, methylation and acetylation influenced by vitamin D and its downstream targets in colorectal cancer to find more potential therapeutic targets. We discuss how vitamin D exerts anticancer properties through interactions between the vitamin D receptor and genes (e.g., SLC30A10), the microenvironment, microbiota and other factors in colorectal cancer. Developing therapeutic approaches targeting the vitamin D signaling system will be aided by a better knowledge of the epigenetic impact of vitamin D.

[1]  Rong Wang,et al.  Inhibition of Nrf2 degradation alleviates age-related osteoporosis induced by 1,25-Dihydroxyvitamin D deficiency. , 2021, Free radical biology & medicine.

[2]  Kunpeng Wang,et al.  Micro1278 Leads to Tumor Growth Arrest, Enhanced Sensitivity to Oxaliplatin and Vitamin D and Inhibits Metastasis via KIF5B, CYP24A1, and BTG2, Respectively , 2021, Frontiers in Oncology.

[3]  A. Javadmanesh,et al.  A DNA methylation panel for high performance detection of colorectal cancer. , 2020, Cancer genetics.

[4]  J. Manson,et al.  Effect of Vitamin D3 Supplements on Development of Advanced Cancer , 2020, JAMA network open.

[5]  M. Abbaszadegan,et al.  Mechanisms of long non‐coding RNA function in colorectal cancer tumorigenesis , 2020, Asia-Pacific journal of clinical oncology.

[6]  R. Wood,et al.  Association Between Histone Deacetylase Activity and Vitamin D-Dependent Gene Expressions in Relation to Sulforaphane in Human Colorectal Cancer Cell. , 2020, Journal of the science of food and agriculture.

[7]  D. Xie,et al.  VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment , 2020, Signal Transduction and Targeted Therapy.

[8]  M. Szyf,et al.  Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma , 2020, Frontiers in Oncology.

[9]  M. Szyf,et al.  S‐adenosylmethionine in combination with decitabine shows enhanced anti‐cancer effects in repressing breast cancer growth and metastasis , 2020, Journal of cellular and molecular medicine.

[10]  M. Szyf,et al.  An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis , 2020, Bone Research.

[11]  F. Casanueva,et al.  Association between variation of circulating 25-OH vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer , 2020, Clinical Epigenetics.

[12]  R. Patalano,et al.  Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells , 2020, Nutrients.

[13]  M. Zheng,et al.  Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology , 2020, Molecular Cancer.

[14]  Yi Wang,et al.  Long Non-coding RNA MEG3 Activated by Vitamin D Suppresses Glycolysis in Colorectal Cancer via Promoting c-Myc Degradation , 2020, Frontiers in Oncology.

[15]  A. Jemal,et al.  Colorectal cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[16]  Chenjing Zhu,et al.  The Oncogenic and Tumor Suppressive Functions of the Long Noncoding RNA MALAT1: An Emerging Controversy , 2020, Frontiers in Genetics.

[17]  A. Javadmanesh,et al.  Crosstalk between DNA methylation and gene expression in colorectal cancer, a potential plasma biomarker for tracing this tumor , 2020, Scientific Reports.

[18]  S. Christakos,et al.  Vitamin D and the intestine: Review and update , 2020, The Journal of Steroid Biochemistry and Molecular Biology.

[19]  A. Goel,et al.  Epigenetics of colorectal cancer: biomarker and therapeutic potential , 2020, Nature Reviews Gastroenterology & Hepatology.

[20]  Guochao Liao,et al.  LSD1/KDM1A inhibitors in clinical trials: advances and prospects , 2019, Journal of Hematology & Oncology.

[21]  Jun Yu,et al.  Gut microbiota in colorectal cancer: mechanisms of action and clinical applications , 2019, Nature Reviews Gastroenterology & Hepatology.

[22]  Yu Zhang,et al.  Association between vitamin D supplementation and mortality: systematic review and meta-analysis , 2019, BMJ.

[23]  Wei Wang,et al.  LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer , 2019, World journal of gastroenterology.

[24]  Xiang Zhou,et al.  The roles of microRNAs in epigenetic regulation. , 2019, Current opinion in chemical biology.

[25]  J. Lulek,et al.  Drug Delivery Systems for Vitamin D Supplementation and Therapy , 2019, Pharmaceutics.

[26]  E. Heard,et al.  Advances in epigenetics link genetics to the environment and disease , 2019, Nature.

[27]  S. Rabbani,et al.  DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications , 2019, Front. Oncol..

[28]  J. Manson,et al.  Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  J. Meyerhardt,et al.  Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial , 2019, JAMA.

[30]  M. Urashima,et al.  Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial , 2019, JAMA.

[31]  A. Crujeiras,et al.  Association between serum 25-hydroxyvitamin D and global DNA methylation in visceral adipose tissue from colorectal cancer patients , 2019, BMC Cancer.

[32]  Xiaozhong Peng,et al.  Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D , 2019, Cell Death & Disease.

[33]  Xianling Cong,et al.  CYP24A1 Inhibition Facilitates the Antiproliferative Effect of 1,25(OH)2D3 Through Downregulation of the WNT/β-Catenin Pathway and Methylation-Mediated Regulation of CYP24A1 in Colorectal Cancer Cells. , 2018, DNA and cell biology.

[34]  W. Willett,et al.  Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts , 2018, Journal of the National Cancer Institute.

[35]  Na Ta,et al.  MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin , 2018, EBioMedicine.

[36]  D. Goltzman Functions of vitamin D in bone , 2018, Histochemistry and Cell Biology.

[37]  H. Baba,et al.  Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers , 2018, Digestion.

[38]  M. Szyf,et al.  Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis in vivo; therapeutic and chemopreventive applications , 2017, Oncotarget.

[39]  J. R. Tejedor,et al.  Distinct chromatin signatures of DNA hypomethylation in aging and cancer , 2017, bioRxiv.

[40]  M. Kerachian,et al.  New insights into colorectal cancer screening and early detection tests , 2017 .

[41]  B. Han,et al.  MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer , 2017, Cellular Physiology and Biochemistry.

[42]  H. Bourbon,et al.  Genome Regulation by Polycomb and Trithorax: 70 Years and Counting , 2017, Cell.

[43]  S. Mukhopadhyay Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14. , 2017, Neurotoxicology.

[44]  Euan J. Rodger,et al.  Epigenetic drivers of tumourigenesis and cancer metastasis. , 2017, Seminars in cancer biology.

[45]  M. Kerachian,et al.  Rising rates of colorectal cancer among younger Iranians: is diet to blame? , 2017, Current oncology.

[46]  M. Duffy,et al.  Vitamin D analogues: Potential use in cancer treatment. , 2017, Critical reviews in oncology/hematology.

[47]  B. Madison,et al.  MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications , 2017, Disease Models & Mechanisms.

[48]  Bin Guo,et al.  Vitamin D and the Epigenetic Machinery in Colon Cancer. , 2017, Current medicinal chemistry.

[49]  H. Fan,et al.  Risk analysis of colorectal cancer incidence by gene expression analysis , 2017, PeerJ.

[50]  Jing Zhu,et al.  H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells , 2017, Neoplasia.

[51]  A. Feinberg,et al.  Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis , 2017, Nature Genetics.

[52]  Yoko Yamamoto,et al.  LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer , 2017, Oncotarget.

[53]  Honghe Zhang,et al.  Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review) , 2016, International journal of oncology.

[54]  H. Schwarzenbach Biological and Clinical Relevance of H19 in Colorectal Cancer Patients , 2016, EBioMedicine.

[55]  G. Kullak-Ublick,et al.  Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[56]  Xinjun Zhang,et al.  Methylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis , 2016, Scientific Reports.

[57]  Dan Zhao,et al.  Clinical significance of HOTAIR expression in colon cancer. , 2016, World journal of gastroenterology.

[58]  C. Rao,et al.  Prevention and treatment of cancers by immune modulating nutrients. , 2016, Molecular nutrition & food research.

[59]  M. Lübbert,et al.  Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy , 2016, Clinical Epigenetics.

[60]  James E Audia,et al.  Histone Modifications and Cancer. , 2016, Cold Spring Harbor perspectives in biology.

[61]  Justin L. Brown,et al.  Polymeric nanoparticles: the future of nanomedicine. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[62]  M. Falzon,et al.  Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells. , 2015, Cancer letters.

[63]  M. Szyf,et al.  Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo , 2015, British journal of pharmacology.

[64]  A. Chan,et al.  Nutrients, foods, and colorectal cancer prevention. , 2015, Gastroenterology.

[65]  M. Szyf,et al.  S-adenosylmethionine blocks osteosarcoma cells proliferation and invasion in vitro and tumor metastasis in vivo: therapeutic and diagnostic clinical applications , 2015, Cancer medicine.

[66]  E. Giovannucci,et al.  Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status , 2015, Gut.

[67]  M. Szyf,et al.  Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness. , 2014, Carcinogenesis.

[68]  F. Cameron,et al.  Inflammation and MiR-21 Pathways Functionally Interact to Downregulate PDCD4 in Colorectal Cancer , 2014, PloS one.

[69]  L. Hesson,et al.  The evidence for functional non-CpG methylation in mammalian cells , 2014, Epigenetics.

[70]  E. Giovannucci,et al.  The role of vitamin D in reducing cancer risk and progression , 2014, Nature Reviews Cancer.

[71]  D. Bikle,et al.  Vitamin D metabolism, mechanism of action, and clinical applications. , 2014, Chemistry & biology.

[72]  C. Morrison,et al.  MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. , 2013, Gastroenterology.

[73]  J. Feliu,et al.  Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis , 2013, Gut.

[74]  P. Horváth,et al.  CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells. , 2013, World journal of gastroenterology.

[75]  H. Fessi,et al.  Nano-encapsulation of Vitamin D3 Active Metabolites for Application in Chemotherapy: Formulation Study and in Vitro Evaluation , 2013, Pharmaceutical Research.

[76]  J. Mathers,et al.  Nutritional factors and gender influence age-related DNA methylation in the human rectal mucosa , 2012, Aging cell.

[77]  J. Knight,et al.  Vitamin D Intake Is Negatively Associated with Promoter Methylation of the Wnt Antagonist Gene DKK1 in a Large Group of Colorectal Cancer Patients , 2012, Nutrition and cancer.

[78]  C. Boland,et al.  A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer , 2012, PloS one.

[79]  M. Veldhoen,et al.  Dietary influences on intestinal immunity , 2012, Nature Reviews Immunology.

[80]  A. Muñoz,et al.  MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. , 2012, Human molecular genetics.

[81]  Yanlei Ma,et al.  Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation , 2012, International journal of cancer.

[82]  M. Campbell,et al.  Vitamin D has wide regulatory effects on histone demethylase genes , 2012, Cell cycle.

[83]  M. Campbell,et al.  KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. , 2011, Human molecular genetics.

[84]  R. Turner,et al.  LINE-1 Hypomethylation During Primary Colon Cancer Progression , 2011, PloS one.

[85]  G. Byrnes,et al.  Meta‐analysis of observational studies of serum 25‐hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma , 2011, International journal of cancer.

[86]  X. Geng,et al.  S-Adenosylmethionine Inhibits the Growth of Cancer Cells by Reversing the Hypomethylation Status of c-myc and H-ras in Human Gastric Cancer and Colon Cancer , 2010, International journal of biological sciences.

[87]  J. Reichrath,et al.  VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[88]  C. Geisler,et al.  Vitamin D controls T cell antigen receptor signaling and activation of human T cells , 2010, Nature Immunology.

[89]  M. Ehrlich DNA hypomethylation in cancer cells. , 2009, Epigenomics.

[90]  Shingo Takagi,et al.  Human CYP24 Catalyzing the Inactivation of Calcitriol Is Post-Transcriptionally Regulated by miR-125b , 2009, Molecular Pharmacology.

[91]  Yuzhuo Pan,et al.  MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting The online version of this article (available at http://dmd.aspetjournals.org) contains supplemental material. , 2009, Drug Metabolism and Disposition.

[92]  Shingo Takagi,et al.  MicroRNA regulates human vitamin D receptor , 2009, International journal of cancer.

[93]  Christian Pilarsky,et al.  Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. , 2009, Clinical chemistry.

[94]  X. Chen,et al.  Role of miR-143 targeting KRAS in colorectal tumorigenesis , 2009, Oncogene.

[95]  Xuening Wang,et al.  MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3 , 2009, Cell cycle.

[96]  Emily J. Greenspan,et al.  HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling , 2008, Cancer biology & therapy.

[97]  S. Ogino,et al.  LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer , 2008, International journal of cancer.

[98]  M. Bitner-Glindzicz,et al.  Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—A new metabolic disorder , 2008, Journal of Inherited Metabolic Disease.

[99]  T. Veenstra,et al.  Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases , 2007, Proceedings of the National Academy of Sciences.

[100]  I. Issaeva,et al.  UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development , 2007, Nature.

[101]  Howard Y. Chang,et al.  A histone H3 lysine 27 demethylase regulates animal posterior development , 2007, Nature.

[102]  G. Natoli,et al.  The Histone H3 Lysine-27 Demethylase Jmjd3 Links Inflammation to Inhibition of Polycomb-Mediated Gene Silencing , 2007, Cell.

[103]  Manel Esteller,et al.  The role of histone deacetylases (HDACs) in human cancer , 2007, Molecular oncology.

[104]  R. Recker,et al.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.

[105]  K. Robertson DNA methylation and human disease , 2005, Nature Reviews Genetics.

[106]  A. Muñoz,et al.  SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications , 2005, British Journal of Cancer.

[107]  Ivan V. Gregoretti,et al.  Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. , 2004, Journal of molecular biology.

[108]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[109]  H. Cross,et al.  25-hydroxy-vitamin d metabolism in human colon cancer cells during tumor progression. , 2001, Biochemical and biophysical research communications.

[110]  M. Szyf,et al.  A mammalian protein with specific demethylase activity for mCpG DNA , 1999, Nature.

[111]  J. Herman,et al.  Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[112]  G. McVeigh,et al.  The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. , 1988, BMJ.

[113]  C. Garland,et al.  Do sunlight and vitamin D reduce the likelihood of colon cancer? , 1980, International journal of epidemiology.

[114]  M. Kerachian,et al.  Long interspersed nucleotide element-1 (LINE-1) methylation in colorectal cancer. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[115]  Xiaoan Ruan,et al.  Expression of VDR and CYP24A1 mRNA in human tumors , 2005, Cancer Chemotherapy and Pharmacology.

[116]  David I. K. Martin,et al.  Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue , 2004, International Journal of Colorectal Disease.